Rani Therapeutics Inc.

NASDAQ: RANI · Real-Time Price · USD
0.55
-0.01 (-1.22%)
At close: Aug 15, 2025, 3:58 PM
0.55
0.00%
After-hours: Aug 15, 2025, 07:04 PM EDT

Rani Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a 172K 1.03M n/a n/a n/a 2.75M n/a n/a n/a n/a n/a n/a n/a -2.72M n/a 1.96M 756K
Cost of Revenue
240K n/a n/a 259K 255K 248K 227K 478K 449K n/a 410K 352K 282K 268K 113K 120K n/a n/a
Gross Profit
-240K 172K 1.03M -259K -255K -248K 2.52M -478K -449K n/a -410K -352K -282K -268K -2.83M -120K 1.96M 756K
Operating Income
-10.51M -12.01M -14.96M -11.8M -12.52M -14.03M -13.43M -17.86M -18.29M -16.52M -17.48M -16.34M -15.85M -13.78M 5.77M -27.78M -5.26M -5.2M
Interest Income
158K 218K 360K 414K 439K 549K 675K 839K 896K 891K 818K 379K 35K 15K 16K 13K 13K 47K
Pretax Income
-6.69M -7.26M -15.72M -12.72M -13.36M -14.78M -14.05M -18.33M -18.66M -16.83M -17.38M -16.32M -15.81M -13.77M -13.35M -28.66M -5.48M -5.55M
Net Income
-6.69M -7.26M -8.95M -6.78M -6.8M -7.48M -7.1M -9.2M -9.3M -8.37M -17.34M -16.21M -15.97M -13.83M -13.22M -3.14M -5.49M -5.6M
Selling & General & Admin
5M 5.62M 5.46M 5.63M 6.41M 6.2M 5.6M 6.63M 7.21M 6.8M 7.1M 7.24M 6.32M 6.19M 5.95M 15.82M 3.46M 2.61M
Research & Development
5.5M 6.57M 6.81M 6.17M 6.12M 7.59M 7.61M 11.22M 11.09M 9.71M 10.39M 9.1M 9.53M 7.59M 7.42M 11.96M 3.76M 3.35M
Other Expenses
n/a n/a 3.71M n/a n/a n/a 227K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
10.51M 12.19M 15.99M 11.8M 12.52M 13.79M 13.43M 17.86M 18.29M 16.52M 17.48M 16.34M 15.85M 13.78M 13.36M 27.78M 7.22M 5.95M
Interest Expense
877K -943K 1.12M 1.34M 1.28M 1.29M 1.3M 1.32M 1.27M 1.21M 719K 352K n/a n/a n/a 110K 169K 188K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a -248K -227K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
10.51M 12.19M 15.99M 11.8M 12.52M 14.03M 13.43M 17.86M 18.29M 16.52M 17.48M 16.34M 15.85M 13.78M 13.36M 27.78M 7.22M 5.95M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -41K -107K 154K 63K -122K 37K 1K 43K
Shares Outstanding (Basic)
36.54M 33.44M 32.66M 28.84M 26.32M 26.03M 25.87M 25.55M 25.34M 25.24M 24.91M 24.47M 24.37M 21.41M 19.53M 19.44M 46.9M 18.74M
Shares Outstanding (Diluted)
36.54M 33.44M 32.66M 28.84M 26.32M 26.03M 25.87M 25.55M 25.34M 25.24M 24.91M 24.47M 24.37M 21.41M 19.53M 19.44M 46.9M 18.74M
EPS (Basic)
-0.18 -0.22 -0.27 -0.24 -0.26 -0.29 -0.27 -0.36 -0.37 -0.33 -0.7 -0.66 -0.66 -0.65 -0.68 -0.16 -0.12 -0.3
EPS (Diluted)
-0.18 -0.22 -0.27 -0.24 -0.26 -0.29 -0.27 -0.36 -0.37 -0.33 -0.7 -0.66 -0.66 -0.65 -0.68 -0.16 -0.12 -0.3
EBITDA
-10.51M -12.01M -14.33M -11.13M -11.83M -13.24M -12.53M -16.54M -16.95M -15.44M -16.25M -15.61M -15.69M -13.65M -13.23M -28.43M -5.19M -5.23M
EBIT
-10.35M -11.79M -14.6M -11.38M -12.09M -13.48M -12.76M -17.02M -17.4M -15.63M -16.66M -15.96M -15.81M -13.77M -13.35M -28.55M -5.32M -5.37M
Depreciation & Amortization
n/a 251K 266K 259K 255K 248K 227K 478K 449K 188K 410K 352K 282K 268K 113K 120K 128K 136K